Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nuvo Pharmaceuticals Inc MRVFF

Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets.


OTCQX:MRVFF - Post by User

Bullboard Posts
Post by Montrose2on May 07, 2009 3:26pm
510 Views
Post# 15975708

VNDA Comparison

VNDA ComparisonHaven't read all of the recent posts so don't know if the following has already been mentioned.

Two significant comparable factors as I see it.

#1 - VNDA went from totally non-approvable to approved.  NRI would seem to have a smaller leap.

#2 - The FDA set May 6 as the target date back in November 08 and released its decision right on the target date.  That would seem to firm up the August 8th(I believe) target date established for NRI.

Onward and Upward.
Bullboard Posts